Tech Company Financing Transactions

Ra Pharmaceuticals Funding Round

Ra Pharmaceuticals closed a $8.6 million Series A funding round on 5/16/2012. Investors included Amgen Ventures, Morgenthaler Ventures and New Enterprise Associates.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
2nd tranche. We will continue to build out our pipeline using our high-diversity drug discovery platform capable of generating optimized lead candidates in a matter of weeks, but also hope to secure discovery and development partnerships as we gain momentum with our internal programs.

Company Information

Company Status
Acquired or Merged
Mailing Address
87 Cambridge Park Dr.
Cambridge, MA 02140
Email Address
Ra Pharmaceuticals is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma's peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability.
Ra Pharmaceuticals LinkedIn Company Profile
Social Media
Ra Pharmaceuticals Company Twitter Account
Company News
Ra Pharmaceuticals News
Ra Pharmaceuticals on Facebook
Ra Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Doug Treco
  Doug Treco LinkedIn Profile  Doug Treco Twitter Account  Doug Treco News  Doug Treco on Facebook
Chief Financial Officer
David Lubner
  David Lubner LinkedIn Profile  David Lubner Twitter Account  David Lubner News  David Lubner on Facebook
Chief Medical Officer
Ramin Farzaneh-Far
  Ramin Farzaneh-Far LinkedIn Profile  Ramin Farzaneh-Far Twitter Account  Ramin Farzaneh-Far News  Ramin Farzaneh-Far on Facebook
Chief Scientific Officer
Simon Read
  Simon Read LinkedIn Profile  Simon Read Twitter Account  Simon Read News  Simon Read on Facebook
VP - R & D
Alonso Ricardo
  Alonso Ricardo LinkedIn Profile  Alonso Ricardo Twitter Account  Alonso Ricardo News  Alonso Ricardo on Facebook



Browse more venture capital transactions:

Prev: 5/16/2012: Mass Relevance venture capital transaction
Next: 5/17/2012: NextIO venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary